← Browse by Condition
Medical Condition

adenocarcinoma

Total Trials
6
Recruiting Now
6
Trial Phases
EARLY_Phase 1, Phase 2, Phase 3
NCT06046131
Recruiting

Clinical, Genetic and Environmental Determinants of Prostate Cancer Progression.

Enrollment
3,000 pts
Location
France, Guadeloupe
Sponsor
Centre Hospitalier Universitai...
View Trial →
NCT05065736 EARLY_Phase 1
Recruiting

Using a PET Imaging Agent, 18F-Clofarabine (CFA), to Measure Deoxycytidine Kinase Activity in Metastatic Cancer

Enrollment
4 pts
Location
United States
Sponsor
Roberto Vargas
View Trial →
NCT06121700 Phase 2
Recruiting

Radiotherapy + Chemoimmunotherapy Followed by Surgery in Patients With Limited Metastatic Gastric or GEJ Cancer

Enrollment
55 pts
Location
China
Sponsor
Fudan University
View Trial →
NCT05581121 Phase 3
Recruiting

PARa-aOrtic LymphAdenectomy in Locally Advanced Cervical Cancer

Enrollment
510 pts
Location
France, Italy, Spain
Sponsor
Institut Claudius Regaud
View Trial →
NCT04401059 Phase 4
Recruiting

Synergistic Effect of Elemene Plus TKIs Compared With TKIs in EGFR-mutated Advanced NSCLC：Prospective Study

Enrollment
744 pts
Location
China
Sponsor
Tian Xie
View Trial →
NCT04361708 Phase 1
Recruiting

Safety of Combining Irinotecan With 5-FU, Leucovorin/Folinic Acid, Oxaliplatin, and Docetaxel Chemotherapies

Enrollment
54 pts
Location
United States
Sponsor
University of Chicago
View Trial →